BioCryst Pharmaceuticals, Inc.【BCRX】 株式報酬費用の推移

機能の使い方
(単位:千ドル) 株式報酬費用 前年比(%)
2024/12 65,413 +17.6%
2023/12 55,615 +24.4%
2022/12 44,701 +29.0%
2021/12 34,640 +134.1%
2020/12 14,794 -16.5%
2019/12 17,719 +88.6%
2018/12 9,396 -25.6%
2017/12 12,621 +48.7%
2016/12 8,487 -12.6%
2015/12 9,705 -4.6%
2014/12 10,177 +133.0%
2013/12 4,368 +4.8%
2012/12 4,167 -12.7%
2011/12 4,772 -